| Literature DB >> 27075340 |
Bing Zhu1,2, Yinghua Li2, Zhengfang Lin2, Mingqi Zhao2, Tiantian Xu2, Changbing Wang2, Ning Deng3.
Abstract
Recently, silver nanoparticles (AgNPs) have been shown to provide a novel approach to overcome tumors, especially those of hepatocarcinoma. However, the anticancer mechanism of silver nanoparticles is unclear. Thus, the purpose of this study was to estimate the effect of AgNPs on proliferation and activation of ROS-mediated signaling pathway on human hepatocellular carcinoma HePG-2 cells. A simple chemical method for preparing AgNPs with superior anticancer activity has been showed in this study. AgNPs were detected by transmission electronic microscopy (TEM) and energy dispersive X-ray (EDX). The size distribution and zeta potential of silver nanoparticles were detected by Zetasizer Nano. The average size of AgNPs (2 nm) observably increased the cellular uptake by endocytosis. AgNPs markedly inhibited the proliferation of HePG-2 cells through induction of apoptosis with caspase-3 activation and PARP cleavage. AgNPs with dose-dependent manner significantly increased the apoptotic cell population (sub-G1). Furthermore, AgNP-induced apoptosis was found dependent on the overproduction of reactive oxygen species (ROS) and affecting of MAPKs and AKT signaling and DNA damage-mediated p53 phosphorylation to advance HePG-2 cells apoptosis. Therefore, our results show that the mechanism of ROS-mediated signaling pathways may provide useful information in AgNP-induced HePG-2 cell apoptosis.Entities:
Keywords: Apoptosis; Cellular uptake; Reactive oxygen species; Silver nanoparticles
Year: 2016 PMID: 27075340 PMCID: PMC4830774 DOI: 10.1186/s11671-016-1419-4
Source DB: PubMed Journal: Nanoscale Res Lett ISSN: 1556-276X Impact factor: 4.703
Fig. 1Structural characterization of AgNPs. a TEM image of AgNPs. b EDX analysis of AgNPs. c Size distribution of AgNPs. d Zeta potential of AgNPs
Fig. 26-coumarin-labeled AgNPs in HePG-2 cells. The HePG-2 cells were treated with 6-coumarin-marked AgNPs for different periods of time and stained with Lyso Tracker Red (lysosome) and DAPI (nucleus) under fluorescent microscope
Fig. 3Growth inhibition AgNPs on HePG-2 Cells. a Cell viability were treated with different concentrations of AgNPs for 72 h and measured by MTT assay. b Morphological changes in HePG-2 cells. Bars with different characters are statistically different at P < 0.05(*) or P < 0.01(**)
Fig. 4Flow cytometric analysis of HePG-2 cells after treated with AgNPs for 72 h stained with PI after fixation by 70 % ethanol. As shown in a and b, the cell cycle distribution after different treatments and apoptotic cell population was determined by PI flow cytometric analysis. Bars with different characters are statistically different at P < 0.05(*) or P < 0.01(**)
Fig. 5ROS overproduction induced by AgNPs. a–c Changes of intracellular ROS generation. ROS levels were detected by DCF fluorescence intensity. Bars with different characters are statistically different at P < 0.05(*) or P < 0.01(**)
Fig. 6Activation of apoptotic signaling pathways by AgNPs in HePG-2 cells. a DNA damage-mediated p53. b–d The expression level of MAPKs, caspase-3, and AKT in HePG-2 cells. The numbers above the images of bands represent the expression level of protein by densitometry analysis